Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
40
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight selling pressure.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.29 | Buy |
20-day SMA: | 0.27 | Buy |
50-day SMA: | 0.29 | Buy |
200-day SMA: | 0.53 | Sell |
8-day EMA: | 0.29 | Buy |
20-day EMA: | 0.28 | Buy |
50-day EMA: | 0.3 | Sell |
200-day EMA: | 0.75 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 54.9 | Buy |
Chaikin Money Flow: | -44360 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.29) | Buy |
Bollinger Bands (100): | (0.27 - 0.35) | Sell |
Cara Therapeutics Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.29 while CARA 8-day simple moving average is 0.29, which is a Buy signal.
- The stock price of CARA is 0.29 while Cara Therapeutics 20-day SMA is 0.27, which makes it a Buy.
- Cara Therapeutics 50-day simple moving average is 0.29 while CARA share price is 0.29, making it a Buy technically.
- CARA stock price is 0.29 and Cara Therapeutics 200-day simple moving average is 0.53, creating a Sell signal.
CARA Technical Analysis vs Fundamental Analysis
Sell
40
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a Sell
The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Cara Therapeutics Stock Info
Market Cap:
15.96M
Price in USD:
0.29
Share Volume:
277.83K
Cara Therapeutics 52-Week Range
52-Week High:
1.32
52-Week Low:
0.24
Sell
40
Cara Therapeutics (CARA)
is a Sell
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?
The Cara Therapeutics stock price is 0.29 USD today. -
Will CARA stock go up or go down?
Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is overvalued.
Is Cara Therapeutics Stock a Buy?
- Cara Therapeutics share price is 0.29 while CARA 8-day exponential moving average is 0.29, which is a Buy signal.
- The stock price of CARA is 0.29 while Cara Therapeutics 20-day EMA is 0.28, which makes it a Buy.
- Cara Therapeutics 50-day exponential moving average is 0.30 while CARA share price is 0.29, making it a Sell technically.
- CARA stock price is 0.29 and Cara Therapeutics 200-day simple moving average is 0.75, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
- CARA Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Cara Therapeutics is a Buy
- Cara Therapeutics Relative Strength Index (RSI) is 54.9, which suggest Cara Therapeutics is overbought
- The Bollinger Bands (25) for Cara Therapeutics is (0.25 - 0.29), which suggest Cara Therapeutics is a Sell
- The Bollinger Bands (100) for Cara Therapeutics is (0.27 - 0.35), which suggest Cara Therapeutics is a Sell
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.